VEGF resistance as a molecular basis to explain the angiogenesis paradox in diabetes mellitus.
about
Cancer biology in diabetes.Glycemic control influences serum angiogenin concentrations in patients with type 2 diabetesAngiogenesis impairment in diabetes: role of methylglyoxal-induced receptor for advanced glycation endproducts, autophagy and vascular endothelial growth factor receptor 2Circulating levels of endothelial progenitor cell mobilizing factors in the metabolic syndrome.Dysfunctional endothelial progenitor cells in metabolic syndromeIncreased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier.Diabetic angiopathy and angiogenic defects.Glycation of vitronectin inhibits VEGF-induced angiogenesis by uncoupling VEGF receptor-2-αvβ3 integrin cross-talk.Downregulation of vascular endothelial growth factor receptor-2 under oxidative stress conditions is mediated by β-transduction repeat-containing protein via glycogen synthase kinase-3β signalingEffect of Blocking of Neuropeptide Y Y2 Receptor on Tumor Angiogenesis and Progression in Normal and Diet-Induced Obese C57BL/6 Mice.Sanguinarine inhibits vascular endothelial growth factor release by generation of reactive oxygen species in MCF-7 human mammary adenocarcinoma cells.MicroRNA-132 may play a role in coexistence of depression and cardiovascular disease: a hypothesis.Expression of microRNAs: potential molecular link between obesity, diabetes and cancer.Effects of diabetes on myocardial capillary density and serum angiogenesis biomarkers in male ratsVascular endothelial growth factors: multitasking functionality in metabolism, health and disease.Molecular controls of arterial morphogenesis.Endothelial cell-dependent regulation of arteriogenesis.Imaging receptor for advanced glycation end product expression in mouse model of hind limb ischemia.Diabetic retinopathy and vascular endothelial growth factor.Myocardial capillary density in normal and diabetic male rats: Effect of bezafibrate.Effect of combined hormonal and insulin therapy on the steroid hormone receptors and growth factors signalling in diabetic mice prostate.Inhibiting the response to VEGF in diabetes.Selenoprotein P as a diabetes-associated hepatokine that impairs angiogenesis by inducing VEGF resistance in vascular endothelial cells.Modulation of VEGF signaling in a mouse model of diabetes by xanthohumol and 8-prenylnaringenin: Unveiling the angiogenic paradox and metabolism interplay.Letter to editor.BMP-2 induces human mononuclear cell chemotaxis and adhesion and modulates monocyte-to-macrophage differentiation
P2860
Q33608038-F325DC8E-472E-4F64-85A9-3E3DD494E6E8Q34016097-EC3F8F13-B84C-4E9C-9BD3-D3A6C05BCFDBQ34441960-50CA8A1F-1CC2-4A65-929F-497129EC8DF6Q34640128-342D86D5-32B9-4AB4-BA94-6B2099DA09D5Q35222376-2A839773-3C98-4C7B-AC50-034682A1B64DQ36070462-A6AC54F7-3270-426D-89E5-D7BFFC8BCECBQ36301365-F65EF14C-2039-4513-9AA1-8B0054725060Q36347376-E750A420-9B87-484B-9971-660C877C4F5FQ36684301-4009F6D7-A2BE-44F1-8066-97CBAF4A55F4Q36718477-6C1B7741-61C0-4579-B528-7CC81C5B1504Q36904634-ECFF9476-AB29-4B2A-837C-E5DC5CBA86AAQ36919632-6F18A87F-77DC-496D-A4C3-C6A72EF4EEACQ37902256-36CE0D35-46E1-4915-9AC9-A15500DBD961Q38258872-29569C95-3A13-45E2-B2EE-DD18B249DCCDQ38418718-385E48DB-20DA-4D6C-9CB9-F4CA23BBAF1DQ38466556-0C90F481-FCE9-4DBE-86DE-71C8610F9A04Q39375877-18AE199D-888A-4B06-B946-82CB94831D04Q40979636-FBC7B075-729B-4BAD-B9C2-44E2EE5C2912Q41836659-A7ED256B-D38E-4EB9-A129-D5B6378AE46FQ42587472-178163FE-93B0-499A-825D-7CAD58728C73Q42840263-40604858-8D64-4F6A-B820-DD1229DDBABDQ46001182-41F05377-DFCB-467A-A7C1-2D325C501882Q46871180-F2204233-E33E-41B0-8654-9A6CEC197F90Q51026280-F8A67F60-F0D1-463B-B7C8-488CFFB2472AQ54381029-88EA4A53-6805-4E1B-B657-48CA07D04712Q58783789-47FFEBA7-B038-43FA-BD2D-0C92783EA6CB
P2860
VEGF resistance as a molecular basis to explain the angiogenesis paradox in diabetes mellitus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
VEGF resistance as a molecular ...... paradox in diabetes mellitus.
@en
VEGF resistance as a molecular ...... paradox in diabetes mellitus.
@nl
type
label
VEGF resistance as a molecular ...... paradox in diabetes mellitus.
@en
VEGF resistance as a molecular ...... paradox in diabetes mellitus.
@nl
prefLabel
VEGF resistance as a molecular ...... paradox in diabetes mellitus.
@en
VEGF resistance as a molecular ...... paradox in diabetes mellitus.
@nl
P356
P1476
VEGF resistance as a molecular ...... s paradox in diabetes mellitus
@en
P2093
Johannes Waltenberger
P304
P356
10.1042/BST0371167
P577
2009-12-01T00:00:00Z